Showing 2301-2310 of 5064 results for "".
Managing Advanced Skin Cancers
https://practicaldermatology.com/conferences/aad-2021/managing-advanced-skin-cancers/19920/Treatment of advanced NMSC can be a challenge, but therapeutic options continue to expand. Todd Schlesinger, MD discusses real-world use of hedgehog inhibitors—including modified regimens and adjuvant use—and PD-1 inhibitors for advanced disease.Emrosi Launched in the US for Rosacea
https://practicaldermatology.com/videos/dermwire-tv/emrosi-launched-in-the-us-for-rosacea/33943/In this week's DermwireTV, a new treatment for rosacea is launched in the US; long-term data is presented for tapinarof 1% cream for atopic dermatitis; and in our C-Suite Chats segment, we speak with the CEO and Co-Founder of Mama Sol.Recognizing Dermatologic Emergencies in Kids
https://practicaldermatology.com/conferences/scale-2023/recognizing-dermatologic-emergencies-in-kids/20198/Infections including congenital infections, syphilis, or HSV are the No. 1 cause of pediatric skin emergencies. Infantile hemangiomas in the airway can affect breathing and also require fast and early treatment, explains Thy Huynh, MD.Evidence-based Skincare
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/evidence-based-skincare/18491/Evidence-based skincare is the foundation of a 360-degree cosmetic rejuvenation plan, says Shannon Humphrey, MD. Hear her number 1 recommendation for all aesthetic patients.Telemedicine: Now What?
https://practicaldermatology.com/topics/practice-management/telemedicine-now-what/23496/Teledermatology is here to stay, but what about pay parity and other pandemic-related expansions?Now What?
https://practicaldermatology.com/topics/psoriasis/now-what/20840/A look at what's now, what's next, and how dermatology practice continues to evolve with drugs, technologies, and opportunities.Non-genital Warts: A Review of Current Treatments
https://practicaldermatology.com/topics/general-topics/non-genital-warts-a-review-of-current-treatments/21884/When determining which treatment modality to choose for non-genital warts, there are several factors to consider, including the convenience of the treatment, patient discomfort, location of warts, and potential side effects.The New Normal in Psoriasis Care
https://practicaldermatology.com/columns/clinical-focus-1/the-new-normal-in-psoriasis-care/23436/Lifestyle changes can help psoriasis patients cope with COVID-19.Continuity of Psoriasis Care in the Era of COVID-19
https://practicaldermatology.com/columns/clinical-focus-1/continuity-of-psoriasis-care-in-the-era-of-covid-19/23285/While there’s no data about susceptibility to COVID-19 in psoriasis, there is relevant information on infectious complications from biologics.Expert Panel Consensus on Uniform Nomenclature and Diagnosis for Neuropathic Pruritus
https://practicaldermatology.com/issues/june-2024/expert-panel-consensus-on-uniform-nomenclature-and-diagnosis-for-neuropathic-pruritus/26549/Dr. Peter Lio and colleagues look at a 2023 article working to establish a consensus on uniform nomenclature and diagnosis for neuropathic pruritis.